Free National NPI Number Registry

Hani Hassoun

Home > Hani Hassoun

 

NPI Number Detailed Information

Provider Information:

Name: Hani Hassoun
Gender: M
Provider License Number If Given: 224714

NPI Information:

NPI: 1285605220
Entity Type
(Individual or Organization):
1-ind
Enumeration Date: 1/29/2006

Last Update Date: 6/10/2008

Reputation Report:

Provider Business Mailing Address:

Address: 633 3RD AVE BOX 3
New York, NY 10017
Phone Number:
Fax Number:

Provider Business Practice Location Address:

Address: 1275 YORK AVE
New York, NY 10021
Phone Number: 2126392000
Fax Number:

Provider Taxonomy:

Primary: 207RH0000X
Secondary (if any):
State: NY

Top Doctors in NY

 

About Hani Hassoun

Hani Hassoun ( HANI HASSOUN ) is An Internal Medicine Physician in New York, NY. The NPI Number for Hani Hassoun is 1285605220.
The current location address for Hani Hassoun is 1275 YORK AVE New York, NY 10021 and the contact number is and fax number is . The mailing address for Hani Hassoun is 633 3RD AVE BOX 3 New York, NY 10017- 2126392000 (mailing address contact number - ).
An internist with additional training who specializes in diseases of the blood, spleen and lymph. This specialist treats conditions such as anemia, clotting disorders, sickle cell disease, hemophilia, leukemia and lymphoma.

Provider Business Location on Map

FAQs:

What is the NPI Number for Hani Hassoun ?


Answer: The NPI Number for Hani Hassoun is 1285605220

Where is Hani Hassoun located?


Answer: Hani Hassoun is located at 1275 YORK AVE New York, NY 10021.

What is the specialty for Hani Hassoun ?


Answer: The Specialty of Hani Hassoun is An Internal Medicine Physician.

Are there any online reviews for Hani Hassoun ?


Answer: Yes! Check It Now.

Are there any other health care providers in New York, NY?


Answer: Yes, there are given below...

Medicare Physician & Other Practitioners

Information on services and procedures provided to Original Medicare (fee-for-service) Part B (Medical Insurance) beneficiaries by Hani Hassoun

Number of HCPCS 15
Number of Medicare Beneficiaries 316
Number of Services 1224
Total Submitted Charge Amount 710515
Total Medicare Allowed Amount 157577.38
Total Medicare Payment Amount 120111.81
Total Medicare Standardized Payment Amount 100495.57
Drug Suppress Indicator
Number of HCPCS Associated With Drug Services 0
Number of Medicare Beneficiaries With Drug Services 0
Number of Drug Services 0
Total Drug Submitted Charge Amount 0
Total Drug Medicare Allowed Amount 0
Total Drug Medicare Payment Amount 0
Total Drug Medicare Standardized Payment Amount 0
Medical Suppress Indicator
Number of HCPCS Associated With Medical Services 15
Number of Medicare Beneficiaries With Medical 316
Number of Medical Services 1224
Total Medical Submitted Charge Amount 710515
Total Medical Medicare Allowed Amount 157577.38
Total Medical Medicare Payment Amount 120111.81
Total Medical Medicare Standardized Payment Amount 100495.57
Average Age of Beneficiaries 74
Number of Beneficiaries Age Less 65 26
Number of Beneficiaries Age 65 to 74 150
Number of Beneficiaries Age 75 to 84 111
Number of Beneficiaries Age Greater 84 29
Number of Female Beneficiaries 155
Number of Male Beneficiaries 161
Number of Non-Hispanic White Beneficiaries 230
Number of Black or African American Beneficiaries 41
Number of Asian Pacific Islander Beneficiaries 11
Number of Hispanic Beneficiaries 16
Number of American Indian/Alaska Native Beneficiaries 0
Number of Beneficiaries With Race Not Elsewhere Classified 18
Number of Beneficiaries With Medicare & Medicaid Entitlement 41
Number of Beneficiaries With Medicare Only Entitlement 275
Percent (%) of Beneficiaries Identified With Atrial Fibrillation 0.15
Percent (%) of Beneficiaries Identified With Alzheimer's Disease or Dementia 0.1
Percent (%) of Beneficiaries Identified With Asthma 0.1
Percent (%) of Beneficiaries Identified With Cancer 0.24
Percent (%) of Beneficiaries Identified With Heart Failure 0.21
Percent (%) of Beneficiaries Identified With Chronic Kidney Disease 0.44
Percent (%) of Beneficiaries Identified With Chronic Obstructive Pulmonary Disease 0.11
Percent (%) of Beneficiaries Identified With Depression 0.22
Percent (%) of Beneficiaries Identified With Diabetes 0.27
Percent (%) of Beneficiaries Identified With Hyperlipidemia 0.58
Percent (%) of Beneficiaries Identified With Hypertension 0.64
Percent (%) of Beneficiaries Identified With Ischemic Heart Disease 0.35
Percent (%) of Beneficiaries Identified With Osteoporosis 0.21
Percent (%) of Beneficiaries Identified With Rheumatoid Arthritis / Osteoarthritis 0.46
Percent (%) of Beneficiaries Identified With Schizophrenia / Other Psychotic Disorders
Percent (%) of Beneficiaries Identified With Stroke 0.07
Average HCC Risk Score of Beneficiaries 2.6662

Medicare Part D Prescribers

Information on prescription drugs provided to Medicare beneficiaries enrolled in Part D (Prescription Drug Coverage), by physicians and other health care providers, aggregated by provider.

Provider Specialty Type Hematology-Oncology
Source of Provider Specialty
Number of Medicare Part D Claims, Including Refills 1183
Number of Standardized 30-Day Fills 1584.5
Aggregate Cost Paid for All Claims 8108901.41
Number of Day's Supply for All Claims 44469
Number of Medicare Beneficiaries 126
Number of Claims, Including Refills, for Beneficiaries Age 65+ 1052
Including Refills, for Beneficiaries Age 65+ 1445.5
Beneficiaries Age 65+ 7178004.75
Number of Day's Supply for All Claims for Beneficaries Age 65+ 40861
Number of Medicare Beneficiaries Age 65+ 112
Reason for Suppression of Brnd_Tot_Clms and Brnd_Tot_Drug_Cst
Total Claims of Brand-Name Drugs 552
Reason for Suppression of Gnrc_Tot_Clms and Gnrc_Tot_Drug_Cst
Total Claims of Generic Drugs, Including Refills 631
Aggregate Cost Paid for Generic Drugs 21970.9
Reason for Suppression of Othr_Tot_Clms and Othr_Tot_Drug_Cst
Total Claims of Other Drugs, Including Refills 0
Aggregate Cost Paid for Other Drugs 0
Reason for Suppression of MAPD_Tot_Clmsand MAPD_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by MAPD Plans 83
Aggregate Cost Paid for Claims Filled by Beneficiaries in MAPD Plans 652984.2
Reason for Suppression of PDP_Tot_Clms and PDP_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by Standalone PDP Plans 1100
Aggregate Cost Paid for Claims Filled by 7455917.21
Reason for Suppression of LIS_Tot_Clms and LIS_Drug_Cst
Number of Claims for Beneficiaries Covered by Low-Income Subsidy 222
Aggregate Cost Paid for Claims Covered by Low-Income Subsidy 1226534.8
Reason for Suppression of NonLIS_Tot_Clms and NonLIS_Drug_Cst
Number of Claims for Beneficiaries Not Covered by Low-Income Subsidy 961
by Low-Income Subsidy 6882366.61
Total Claims of Opioid Drugs, Including 33
Aggregate Cost Paid for Opioid Drugs 1851.65
Opioid Claims 11
Opioid_Tot_Clms divided by the Tot_Clms 2.7895181741
Total Claims of Long-Acting Opioid Drugs 20
Aggregate Cost Paid for Long-Acting Opioid 1697.35
Number of Day's Supply of All Long-Acting 598
Long-Acting Opioid Claims
Opioid_LA_Tot_Clms divided by the 60.606060606
Total Claims of Antibiotic Drugs, Including
Aggregate Cost Paid for Antibiotic Drugs
Antibiotic Claims
Reason for Suppression of Antpsyct_GE65_Tot_Clms and Antpsyct_GE65_Tot_Drug_Cst
Including Refills, for Beneficiaries Age 65+ 0
Aggregate Cost Paid for AntipsychoticDrugs for Beneficiaries Age 65+ 0
Reason for Suppression of Antpsyct_GE65_Tot_Benes
Number of Medicare Beneficiaries Age 65+Filling Antipsychotic Claims 0
Average Age of Beneficiaries 72.76984127
Number of Beneficiaries Age Less Than 65
Number of Beneficiaries Age 65 to 74 61
Number of Beneficiaries Age 75 to 84 45
Number of Female Beneficiaries 69
Number of Male Beneficiaries 57
Number of Non-Hispanic White 79
Number of Black or African American 20
Number of Asian Pacific Islander
Number of Hispanic Beneficiaries
Number of American Indian/Alaskan NativeBeneficiaries 0
Number of Beneficiaries with Race Not 11
Only Entitlement 104
Average Hierarchical Condition Category 3.0631706687

More Providers in new-york , ny

hani hassoun in Other Directories

Provider don't have other directory link yet.